NHS

Neuberger Berman High Yield Strategies Fund Inc. [NHS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

NHS Stock Summary

NHS's dividend payments are well covered by cash flows with cash payout ratio of 78.33%.

Earnings are expected to fall -100% next year

NHS has less than 1 year of cash runway

Top 10 Correlated ETFs

NHS

Top 10 Correlated Stocks

NHS

In the News

05:04 10 Jun 2023 NHS

83 Monthly-Paying Dividend Stocks And 80 Funds For May

Imagine stocks or funds that pay out their dividends once-a-month! Unlike waiting for quarterly, semi-annual or (ugh) annual payouts, your angst waiting for money is reduced by 300%, or more! These May U.S. exchange-traded monthly-paid (MoPay) dividends, upsides, and net gains include: 1. Stocks by yield (83); 2. Stocks by price upside (30); 3. Closed-End Investments, Exchange-Traded Funds & Notes (CEICs/ETFs/ETNs) by yield >9.56% (80).

01:49 10 Jun 2023 NHS

NHS: 2023 Rights Offering Quick Notes

Quick notes on Neuberger Berman High Yield Strategies' rights offering this year. Our suggestion is to sell before the ex-rights date and rebuy after the offering.

05:49 10 Jun 2023 NHS

NHS: Time To Reduce Some Exposure To This High Beta HY CEF

NHS is a fixed income closed end fund. The fund focuses on U.S. high yield bonds, which represent 88% of the portfolio.

06:55 10 Jun 2023 NHS

NHS: 13% Yield From A High Duration Bond CEF

NHS is a fixed income closed end fund. Over 88% of the fund holdings are fixed rate high yield bonds.

10:15 10 Jun 2023 NHS

The Month In Closed-End Funds: October 2022

For the first month in three, equity CEFs (+4.49%) on average witnessed plus-side returns, while their fixed income CEF cohorts (-5.07%) suffered a third month of declines in October. Only 17% of all CEFs traded at a premium to their NAV at month end, with 24% of equity CEFs and 11% of fixed income CEFs trading in premium territory.

03:46 10 Jun 2023 NHS

NHS: Rights Offering Quick Notes

NHS's rights offering is now live. The subscription formula has a floor of a -13% discount, at which point one should not subscribe.

04:30 10 Jun 2023 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK, Sept. 30, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock.

04:30 10 Jun 2023 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK , Aug. 31, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on September 30, 2021, has a record date of September 15, 2021 and has an ex-date of September 14, 2021.

12:43 10 Jun 2023 NHS

Evaluating CEFs: NHS Too Expensive For Its Weak Distribution Coverage

The 8.6% yield for NHS looks very attractive if the distribution can be supported. I continue my series looking beyond the yield of a CEF.

04:30 10 Jun 2023 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK, July 30, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on August 31, 2021, has a record date of August 16, 2021 and has an ex-date of August 13, 2021.

NHS Financial details

Company Rating

Buy

Market Cap

148.18M

Income

29.3M

Revenue

39.15M

Book val./share

Cash/share

Dividend

1.18

Dividend %

15.55%

Employees

Optionable

Shortable

Yes

Earnings

P/E

-3.98

Forward P/E

PEG

-0.38

P/S

-4.87

P/B

0.79

P/C

P/FCF

-3.04

Quick Ratio

1.72

Current Ratio

1.72

Debt / Equity

0.75

LT Debt / Equity

0.27

EPS (TTM)

3.12

EPS next Y

EPS next Q

EPS this Y

-224.84%

EPS next Y

EPS next 5Y

EPS last 5Y

64.2%

Revenue last 5Y

105.21%

Revenue Q/Q

-12.3%

EPS Q/Q

-83.03%

SMA20

-11.11%

SMA50

SMA100

-11.11%

Inst Own

Inst Trans

ROA

-11%

ROE

-19%

ROC

-0.11%

Gross Margin

100%

Oper. Margin

107%

Profit Margin

110%

Payout

-54%

Shs Outstand

19.45M

Shs Float

19.13M

Target Price

52W Range

7.4-9.82

52W High

-15.5%

52W Low

+8.64%

RSI

Rel Volume

1.14

Avg Volume

91.16K

Volume

103.6K

Perf Week

-0.85%

Perf Month

-16.15%

Perf Quarter

-13.09%

Perf Half Y

-14.65%

Beta

0.98698

Volatility

0.02%, 0.57%

Prev Close

-0.07%

Price

7.605

Change

0.07%

NHS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-10-31

Metric	2018-10-31	2019-10-31	2020-10-31	2021-10-31	2022-10-31
Revenue per share	-0.04	1.31	0.32	1.68	-1.73
Net income per share	-0.16	1.16	0.16	1.53	-1.91
Operating cash flow per share	0.83	1.08	1.12	5.95	-2.78
Free cash flow per share	0.83	1.08	1.12	5.95	-2.78
Cash per share	0	0.04	0	0	0
Book value per share	12.59	12.75	12.14	10.34	9.61
Tangible book value per share	12.59	12.75	12.14	10.34	9.61
Share holders equity per share	12.59	12.75	12.14	10.34	9.61
Interest debt per share	4.8	4.81	1.84	1.68	2.68
Market cap	199.67M	231.66M	203.04M	230.15M	143.8M
Enterprise value	289.55M	320.82M	235.63M	259.19M	189.69M
P/E ratio	-64.56	10.28	67.19	8.59	-4.29
Price to sales ratio	-239.2	9.08	33.47	7.8	-4.73
POCF ratio	12.47	11.06	9.59	2.21	-2.95
PFCF ratio	12.47	11.06	9.59	2.21	-2.95
P/B Ratio	0.82	0.94	0.89	1.27	0.85
PTB ratio	0.82	0.94	0.89	1.27	0.85
EV to sales	-346.87	12.58	38.84	8.78	-6.24
Enterprise value over EBITDA	-2.1K	12.37	45.95	9.52	-5.84
EV to operating cash flow	18.09	15.31	11.13	2.49	-3.9
EV to free cash flow	18.09	15.31	11.13	2.49	-3.9
Earnings yield	-0.02	0.1	0.01	0.12	-0.23
Free cash flow yield	0.08	0.09	0.1	0.45	-0.34
Debt to equity	0.55	0.55	0.57	0.62	0.75
Debt to assets	0.36	0.35	0.36	0.38	0.43
Net debt to EBITDA	-652.84	3.44	6.36	1.07	-1.41
Current ratio	0	1.15	2.86	0.66	1.72
Interest coverage	0	7.63	2.43	63.23	-31.93
Income quality	-5.18	0.93	7	3.89	1.45
Dividend Yield	0.08	0.08	0.1	0.07	0.13
Payout ratio	-5.21	0.81	7.02	0.61	-0.54
Sales general and administrative to revenue	-0.79	0.05	0.23	0.03	-0.02
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	6.73	18.24	6.61	18.87	20.33
ROIC	0	0.07	0.01	0.1	-0.11
Return on tangible assets	-0.01	0.06	0.01	0.09	-0.11
Graham Net	-6.61	-6.53	-6.69	-6.19	-6.99
Working capital	0	1.57M	3.79M	-2.1M	2.58M
Tangible asset value	243.32M	247.52M	229.32M	181.09M	168.28M
Net current asset value	-134.69M	-123.96M	-124.92M	-107.4M	-120.87M
Invested capital	0.37	0.36	0.14	0.16	0.27
Average receivables	8.59M	10.15M	8.43M	4.97M	5.15M
Average payables	6.94M	8.95M	6.14M	4.14M	4.92M
Average inventory	0	0	0	0	0
Days sales outstanding	-4.04K	158.17	349.01	51.23	-74.08
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	-0.09	2.31	1.05	7.12	-4.93
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	-0.01	0.09	0.01	0.15	-0.2
Capex per share	0	0	0	0	0

Quarterly Fundamentals Overview

Last date of statement is 2022-10-31 for Q4

Metric	2020-10-31	2021-04-30	2021-10-31	2022-04-30	2022-10-31
Revenue per share	0	0	0	0	0
Net income per share	0	0	0	0	0
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	0	0	0	0	0
Book value per share	0	0	0	0	0
Tangible book value per share	0	0	0	0	0
Share holders equity per share	0	0	0	0	0
Interest debt per share	0	0	0	0	0
Market cap	0	0	0	0	0
Enterprise value	32.6M	21.78M	29.03M	19.32M	45.89M
P/E ratio	0	0	0	0	0
Price to sales ratio	0	0	0	0	0
POCF ratio	0	0	0	0	0
PFCF ratio	0	0	0	0	0
P/B Ratio	0	0	0	0	0
PTB ratio	0	0	0	0	0
EV to sales	0	0	0	0	0
Enterprise value over EBITDA	0	0	0	0	0
EV to operating cash flow	0	0	0	0	0
EV to free cash flow	0	0	0	0	0
Earnings yield	0	0	0	0	0
Free cash flow yield	0	0	0	0	0
Debt to equity	0.57	0.56	0.62	0.65	0.75
Debt to assets	0.36	0.36	0.38	0.39	0.43
Net debt to EBITDA	0	0	0	0	0
Current ratio	0	0	0	1.65	1.72
Interest coverage	0	0	0	0	0
Income quality	0	0	0	0	0
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	0	0	0	0	0
ROIC	0	0	0	0	0
Return on tangible assets	0	0	0	0	0
Graham Net	0	0	0	0	0
Working capital	0	0	0	2M	2.58M
Tangible asset value	229.32M	185.91M	181.09M	153.76M	168.28M
Net current asset value	-130.74M	-104.69M	-111.54M	-94.39M	-120.87M
Invested capital	0.14	0.13	0.16	0.13	0.27
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0	0	0	0	0
Capex per share	0	0	0	0	0

NHS Dividend History

NHS Frequently Asked Questions

What is Neuberger Berman High Yield Strategies Fund Inc. stock symbol ?

Neuberger Berman High Yield Strategies Fund Inc. is a US stock , located in New york of Ny and trading under the symbol NHS

What is Neuberger Berman High Yield Strategies Fund Inc. stock quote today ?

Neuberger Berman High Yield Strategies Fund Inc. stock price is $7.605 today.

Is Neuberger Berman High Yield Strategies Fund Inc. stock public?

Yes, Neuberger Berman High Yield Strategies Fund Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 91.16K
Market Capitalization 148.18M
CEO Mr. Joseph Vincent Amato
Headquarters New York,NY,US
IPO Date 2003-07-29
Website https://www.nb.com/Pages/Public/en-us/Products/high-yield-strategies-fund.aspx

Neuberger Berman High Yield Strategies Fund Inc. is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. It was formerly known as Neuberger Berman High Yield Strategies Fund. Neuberger Berman High Yield Strategies Fund Inc. was formed on July 28, 2003 and is domiciled in the United States.